Tory Burch Fellowship News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A Business Case for Investing in Women Scientists May 27, 2021 Imagine being among the pioneering women scientists  in this case, a physicist  in your twenties. Then, you realize that your doctoral dissertation is so remarkable that not only can your findings point the way toward accelerating the development of life-saving medicines, but your colleagues now want to start a business with you to scale the technology. This swift progress has been a reality for Dr. Nabiha Saklayen, CEO and co-founder of Cellino. Her vision is to automate personalized, autologous cell therapies. Stem cell-derived therapies and regenerative medicines potentially could cure some diseases, including Parkinson’s, diabetes and heart disease. Using a patient’s own cells is by many accounts the safest and most effective way to regenerate healthy tissue for the person’s body. However, most autologous cell therapies are manual-labor intensive and come with costly laboratory overhead. Cellino is work

Nabiha saklayenTory burchHaley stevensJennifer doudnaLaguna pharmaceuticalsInnovative genomics instituteFast companyInternational genomics instituteRevision opticsNobel prizeTory burch fellowshipKhosla venturesடோரி புர்ச்ஹேலி ஸ்டீவன்ஸ்லகுனா மருந்துகள்புதுமையானது மரபியல் நிறுவனம்